Trial News & Events

Temple researchers receive grants to develop ALS therapy, EEG software


The University City Science Center in Philadelphia has awarded Temple two proof-of-concept grants: one for the development of a novel therapy for the treatment of amyotrophic lateral sclerosis (ALS) and another for the creation of a software program that will hone physicians’ ability to read and diagnose electroencephalography, or EEGs.

First Regional CRLI Held in Philadelphia, PA


NEALS Executive Committee Member Terry Heiman-Patterson, MD (Drexel University and the ALS Hope Foundation) leads this effort with the goal of providing advocacy training to PALS in and around the surrounding areas. 

Call for Abstracts - 2013 Annual NEALS Meeting

On behalf of the Executive and Abstract Committees for the 12th Annual NEALS Meeting, we would like to extend an invitation for members to submit an abstract for consideration for presentation at the Annual Meeting.

Prize4Life and Knopp Announce Donation of Empower Phase 3 Data to PRO-ACT Database

Knopp Biosciences, Inc. has agreed to donate placebo data from the phase III  dexpramipexole trial to the award-winning PRO-ACT Platform, created by the NCRI and Prize4Life in partnership with NEALS.  The dataset will be expanded to include treatment-arm data when research into dexpramipexole for ALS is complete.  NCRI and NEALS in collaboration with Prize4life will continue to foster encouraging collaborative partnerships between academia and industry via this valuable resource.